nocarcinoma to the leg, as occurred in the case described here. The dermatomal distribution of the lesions accompanied by neuralgia and hyperaesthesia led the physician to conclude that the patient had herpes zoster.
Erythema Elevatum Diutinum in a Patient with Human Herpesvirus 6 Infection
Sir, Several cases of erythema elevatum diutinum (EED) have recently been found to be associated with human immunode¢-ciency virus (HIV) infection (1^3), supporting the hypothesis that an infectious agent plays a role in its aetiology (4) . We describe here an HIV-negative patient with evidence of human herpesvirus 6 (HHV-6) infection who developed EED.
CASE REPORT
In September 1996 a 50-year-old white woman in apparently good health developed a papulo-nodular eruption on the limbs. On examination, she exhibited a symmetrical, di¡use papulo-nodular eruption on the outer surface of thighs ( Fig. 1) , buttocks and ¢nger joints, and some plaques over the knees and elbows. The ear lobes and face were also involved (Fig. 2) . The lesions were indurated, circinate or oval with central atrophy, purplish to reddish-brown in colour. Neither arthralgia nor other subjective complaints were noted.
A biopsy specimen showed a dense perivascular leucocytoclastic in¢ltrate in the papillary and reticular dermis consistent with EED. Direct immuno£uorescence was negative. Laboratory tests including blood cell count, renal and liver functions were within normal ranges. There was no evidence of streptococcal infection. Chest X-rays and abdominal ecography were also normal. Paraproteinaemia and cryoglobulins were absent and tumoural markers negative.
Immunological investigations showed only a faint ANA positivity on HEP2 cells (1/40 speckled IgM and IgG). Anti-HHV-6 were positive (IgM 1/80 and IgG 1/20), while antibodies against other viruses were negative or indicative of immunity. When ¢rst examined, the patient had been taking 30 mg de£azacort daily for 1 month. The lesions had worsened, however, and the treatment was stopped. In the absence of any treatment, the lesions began to improve and 1 month later the anti-HHV-6 IgM titre was 1/20 and anti-HHV-6 IgG 1/80.
Treatment with 100 mg dapsone daily was started. One month later, the skin lesions had clearly improved and the anti-HHV-6 IgG titer decreased to 1/40. IgM were still 1/20. The drug was reduced to 50 mg daily and, 1 month later, discontinued. The disease did not relapse. DISCUSSION EED is a rare chronic form of cutaneous vasculitis of unknown aetiology that is considered an immune-complex mediated reaction. The disease may be associated with streptococcal infections, in£ammatory bowel disease, haematological disorders (4) and, less frequently, with other pathologies (4, 5) including HIV infection (1^3).
In the patient described here, an infectious cause may be suggested by the exacerbation of her lesions with the steroidal therapy and by their prompt amelioration with the corticosteroid discontinuation (6) .
In addition, this patient disclosed speci¢c anti-HHV-6 IgM and an increase in the titre of anti-HHV-6 IgG. These serological ¢ndings may be interpreted as a seroconversion during a primary HHV-6 infection or as HHV-6 endogenous reactivation (7). HHV-6 infection usually occurs during infancy and persists in a lifelong latent state (8) . Primary infection may cause exanthem subitum in children (9), but frequently is inapparent or results in febrile illness without any rash. In adults, the primary infection is very rare, consisting of a mononucleosis-like illness, prolonged lymphadenopathy or hepatitis (10) .
HHV-6 IgM antibodies can be detected both in primary infections and in reactivation states. Anti-HHV-6 IgG antibodies are present in 80^90% of adults and tend to disappear over time (8) . An increase in the titres of IgG to HHV-6, therefore, is considered indicative of reactivation. In the absence of other viral cross-reactivities, such as EBV or CMV active infections, the speci¢c anti-HHV-6 IgM and the increased titres of IgG make an HHV-6 endogenous reactivation most likely. The rarity of the primary infection in adults and its usual severe course are additional evidences.
Whether EED cutaneous lesions might be determined directly by the HHV-6 reactivation state or may be a mere coincidence, cannot be established by a single case.
